| # | Title | Journal | Year | Citations |
|---|
| 1 | ESMO consensus guidelines for the management of patients with metastatic colorectal cancer | Annals of Oncology | 2016 | 2,545 |
| 2 | Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial | Lancet, The | 1999 | 1,493 |
| 3 | Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial | Lancet, The | 2014 | 1,295 |
| 4 | ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making | Annals of Oncology | 2012 | 1,233 |
| 5 | Tertiary lymphoid structures improve immunotherapy and survival in melanoma | Nature | 2020 | 1,209 |
| 6 | Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study | Annals of Oncology | 2013 | 792 |
| 7 | Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial | Lancet, The | 2003 | 626 |
| 8 | A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 | Radiotherapy and Oncology | 1998 | 523 |
| 9 | Effect of Obesity on Prognosis After Early-Stage Breast Cancer | Journal of Clinical Oncology | 2011 | 477 |
| 10 | 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients | Annals of Oncology | 2016 | 454 |
| 11 | Bone health in cancer patients: ESMO Clinical Practice Guidelines | Annals of Oncology | 2014 | 450 |
| 12 | Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline | European Journal of Cancer | 2015 | 404 |
| 13 | Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden | Radiotherapy and Oncology | 2011 | 389 |
| 14 | MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer | JAMA - Journal of the American Medical Association | 2014 | 380 |
| 15 | Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial | BMJ: British Medical Journal | 2009 | 378 |
| 16 | Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus | JAMA Oncology | 2019 | 366 |
| 17 | Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines | European Journal of Cancer | 2019 | 345 |
| 18 | Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016 | European Journal of Cancer | 2016 | 330 |
| 19 | Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline | European Journal of Cancer | 2015 | 320 |
| 20 | Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model | British Journal of Cancer | 2005 | 287 |
| 21 | Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study | Cancer | 1986 | 268 |
| 22 | Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines | Radiotherapy and Oncology | 2018 | 244 |
| 23 | Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer | Breast Cancer Research and Treatment | 2013 | 242 |
| 24 | Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force | Annals of Oncology | 2014 | 240 |
| 25 | Late effects of breast cancer treatment and potentials for rehabilitation | Acta Oncológica | 2011 | 229 |
| 26 | Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality | British Journal of Cancer | 2012 | 222 |
| 27 | Salivary gland carcinoma in Denmark 1990–2005: A national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA) | Oral Oncology | 2011 | 202 |
| 28 | Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up | Annals of Oncology | 2015 | 188 |
| 29 | Self-reported arm-lymphedema and functional impairment after breast cancer treatment – A nationwide study of prevalence and associated factors | Breast | 2010 | 185 |
| 30 | Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry | Journal of Neuro-Oncology | 2017 | 185 |
| 31 | European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment | European Journal of Cancer | 2020 | 181 |
| 32 | PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer | Clinical Cancer Research | 2011 | 180 |
| 33 | Tumour‐associated microglia/macrophages predict poor prognosis in high‐grade gliomas and correlate with an aggressive tumour subtype | Neuropathology and Applied Neurobiology | 2018 | 178 |
| 34 | The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial | Radiotherapy and Oncology | 2011 | 176 |
| 35 | Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group. | Journal of Clinical Oncology | 1996 | 170 |
| 36 | Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma | Annals of Oncology | 2019 | 170 |
| 37 | The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer | Cancer Epidemiology Biomarkers and Prevention | 2014 | 169 |
| 38 | Global cancer control: responding to the growing burden, rising costs and inequalities in access | ESMO Open | 2018 | 169 |
| 39 | The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer | British Journal of Cancer | 2008 | 168 |
| 40 | Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections | British Journal of Cancer | 1996 | 162 |
| 41 | Single Arc Volumetric Modulated Arc Therapy of head and neck cancer | Radiotherapy and Oncology | 2010 | 159 |
| 42 | Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement | International Journal of Radiation Oncology Biology Physics | 2020 | 156 |
| 43 | Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group | Acta Oncológica | 2013 | 155 |
| 44 | Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial | Journal of Clinical Oncology | 2020 | 155 |
| 45 | European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 | European Journal of Cancer | 2020 | 154 |
| 46 | Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives | Acta Oncológica | 2015 | 153 |
| 47 | A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program | European Urology | 2014 | 151 |
| 48 | Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer? | Annals of Surgery | 2015 | 151 |
| 49 | A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA) | Gynecologic Oncology | 1993 | 147 |
| 50 | Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer | Radiotherapy and Oncology | 2014 | 144 |
